Skip to content

Guardant Health

US · GH #820 by market cap Listed 2018
145.83 +0.24 +0.16%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65
    Market Newswire · 2026/11/9
  • Rating change
    Roth MKM Initiates Guardant Health(GH.US) With Buy Rating, Announces Target Price $200
    Market Newswire · 2026/10/23
  • Rating change
    A Quick Look at Today's Ratings for Guardant Health(GH.US), With a Forecast Between $180 to $220
    Market Newswire · 2026/11/7
  • Rating change
    J.P. Morgan Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $195
    Market Newswire · 2026/10/14
  • Company notice
    HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHD
    Bursa Malaysia · 2026/2/12
  • Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $46
    Market Newswire · 2026/11/18
  • Rating change
    Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $210
    Market Newswire · 2026/10/19
  • GH Research Is Maintained at Buy by HC Wainwright & Co.
    Dow Jones · 2026/11/17
  • Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Cuts Target Price to $190
    Market Newswire · 2026/11/19
  • Company notice
    GH Advanced Materials: Report on Status of Specific Securities, Etc. Owned by Executives and Major Shareholders
    OPENDART · 2026/10/7
  • Company notice
    GH Research | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(12.9%),Peter Kolchinsky(12.9%), etc.
    SEC · 2024/11/15
  • Rating change
    RBC Capital Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $42
    Market Newswire · 2026/11/10
  • Rating change
    Piper Sandler Maintains Guardant Health(GH.US) With Buy Rating, Cuts Target Price to $190
    Market Newswire · 2026/11/10
  • Company notice
    HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHD
    Bursa Malaysia · 2026/1/29
  • Rating change
    Morgan Stanley Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $200
    Market Newswire · 2026/10/20
  • CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39
    Market Newswire · 2026/11/16
  • Rating change
    Barclays Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $220
    Market Newswire · 2026/11/6
  • Rating change
    BTIG Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $210
    Market Newswire · 2026/10/27
  • Company notice
    HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHD
    Bursa Malaysia · 2026/5/19
  • H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Cuts Target Price to $55
    Market Newswire · 2026/11/17
  • Rating change
    Barclays Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $220
    Market Newswire · 2026/10/7
  • Rating change
    Barclays Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $200
    Market Newswire · 2026/9/18
  • Rating change
    Analysts Are Bullish on These Healthcare Stocks: NeurAxis, Inc. (NRXS), Guardant Health (GH)
    TipRanks · 2026/9/16
  • Rating change
    Goldman Sachs Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $225
    Market Newswire · 2026/9/21
  • Rating change
    Morgan Stanley Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $200
    Market Newswire · 2026/10/12

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.

Guardant Health discussion 0 comments

Add a comment